Should people who don't have high cholesterol take a cholesterol-lowering statin? Maybe, according to the U.S. Food and Drug Administration, which is considering an advisory panel's recent recommendation to do just that.
Healthy men and women with good cholesterol levels could significantly reduce their risk of heart disease by taking cholesterol-lowering drugs, better known as statins, according to a study released at the American Heart Association meetings in November.
More consumers, struggling to contain medical expenses, are resorting to "pill cutting" to makes their prescriptions last longer.
Fish oil supplements may work slightly better than a popular cholesterol-reducing drug to help patients with chronic heart failure
UK drugmaker AstraZeneca suffers a drop in earnings. CNN's Charles Hodson speaks with CEO David Brennan.
Cholesterol-lowering statins - which include the world's top-selling drug, Lipitor - and other drugs called fibrates can lower the risk of developing a common form of nerve damage in diabetics that often results in amputations, according to study results unveiled Friday.
An experimental drug from AtheroGenics and its partner AstraZeneca failed a late-stage clinical trial and is not considered an effective treatment in reducing heart disease, the companies said.
Getting cheaper prescription drugs from Canada just got easier. The Department of Homeland Security won't be confiscating medicine shipped from Canada to the United States. But before you go online, we're going to tell you what you need to know about this policy change.
Merck and Schering-Plough announced a study on Sunday showing that their combination drug Vytorin is better at lowering cholesterol than competing drug Crestor from AstraZeneca.
Anglo-Swedish pharmaceutical AstraZeneca said Monday that its blockbuster anti-cholesterol treatment Crestor has passed a key scientific trial.
Vytorin, a relatively new cholesterol-blocking drug from Merck and Schering-Plough, has outpaced sales of a blockbuster rival, according to a report Monday from Friedman, Billings, Ramsey & Co.
Drugmakers have cut television ad spending by 10 percent in the first quarter from a year ago, the sharpest decline in two years, a newspaper said Tuesday.
When Merck yanked the arthritis wonder drug Vioxx off shelves this fall, it not only devastated the company's stock and reputation, it raised fears about the safety of every big new drug. After all...
Will one statin a day keep the doctor away? That's the question Americans and their doctors are asking as medical research suggests the drugs do far more than lower cholesterol. The buzz started ...
The share of new prescriptions written for the cholesterol-lowering drug Lipitor surged during the past week as the Pfizer Inc. (PFE) blockbuster got a boost from a big study showing it was better than Bristol-Myers Squibb Co.'s ( BMY) Pravachol in preventing heart attacks, Thursday's Wall Street Journal reported.
Actuaries, not economists, are the truly dismal scientists. Consider some actuarial projections about the graying America of 2050: One in 26 of us will have Alzheimer's disease, compared with one i...
Fortune: Healthupdated: Mon Dec 09 2002 00:01:00
Move over, cholesterol. The latest heart-attack culprit is C-reactive protein (CRP). CRP, which is produced when arteries are inflamed, was nailed in a groundbreaking November New England Journal o...
What do you call a drug company on Viagra? Pfizer, of course.
© 2013 Cable News Network. Turner Broadcasting System, Inc. All Rights Reserved.
|